These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 31162104)

  • 1. International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
    Hillengass J; Usmani S; Rajkumar SV; Durie BGM; Mateos MV; Lonial S; Joao C; Anderson KC; García-Sanz R; Riva E; Du J; van de Donk N; Berdeja JG; Terpos E; Zamagni E; Kyle RA; San Miguel J; Goldschmidt H; Giralt S; Kumar S; Raje N; Ludwig H; Ocio E; Schots R; Einsele H; Schjesvold F; Chen WM; Abildgaard N; Lipe BC; Dytfeld D; Wirk BM; Drake M; Cavo M; Lahuerta JJ; Lentzsch S
    Lancet Oncol; 2019 Jun; 20(6):e302-e312. PubMed ID: 31162104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of
    Cavo M; Terpos E; Nanni C; Moreau P; Lentzsch S; Zweegman S; Hillengass J; Engelhardt M; Usmani SZ; Vesole DH; San-Miguel J; Kumar SK; Richardson PG; Mikhael JR; da Costa FL; Dimopoulos MA; Zingaretti C; Abildgaard N; Goldschmidt H; Orlowski RZ; Chng WJ; Einsele H; Lonial S; Barlogie B; Anderson KC; Rajkumar SV; Durie BGM; Zamagni E
    Lancet Oncol; 2017 Apr; 18(4):e206-e217. PubMed ID: 28368259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging.
    Mosebach J; Thierjung H; Schlemmer HP; Delorme S
    Rofo; 2019 Nov; 191(11):998-1009. PubMed ID: 31137045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma Australia.
    Creeper K; Augustson B; Kusel K; Fulham MJ; Ho J; Quach H; Mollee P; Weber N; Talaulikar D; Johnston A; Murphy N; Joshua D; Ward C; Ling S; Gibson J; Szer J; Harrison S; Zannettino A; Jaksic W; Lee C; Spencer A; Kalff A; Szabo F; Romeril K; Chan H; Gibbs S; Horvath N; Prince HM
    Intern Med J; 2021 Oct; 51(10):1707-1712. PubMed ID: 34664367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of MRI and computed tomography in the various stages of plasma cell disorders: correlations with biological and histological findings. Myélome-Midi-Pyrénées Group.
    Laroche M; Assoun J; Sixou L; Attal M
    Clin Exp Rheumatol; 1996; 14(2):171-6. PubMed ID: 8737723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Multiple myeloma: current recommendations for imaging].
    Hillengass J; Delorme S
    Radiologe; 2012 Apr; 52(4):360-5. PubMed ID: 22441560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of imaging techniques in the management of multiple myeloma.
    Zamagni E; Cavo M
    Br J Haematol; 2012 Dec; 159(5):499-513. PubMed ID: 22881361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
    Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
    Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imaging in smoldering (asymptomatic) multiple myeloma. Past, present and future].
    Bhutani M; Landgren O
    Radiologe; 2014 Jun; 54(6):572, 574-81. PubMed ID: 24927659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates and Ongoing Challenges in Imaging of Multiple Myeloma:
    Wu F; Bernard S; Fayad LM; Ilaslan H; Messiou C; Moulopoulos LA; Mulligan ME
    AJR Am J Roentgenol; 2021 Oct; 217(4):775-785. PubMed ID: 33978464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
    Dimopoulos M; Terpos E; Comenzo RL; Tosi P; Beksac M; Sezer O; Siegel D; Lokhorst H; Kumar S; Rajkumar SV; Niesvizky R; Moulopoulos LA; Durie BG;
    Leukemia; 2009 Sep; 23(9):1545-56. PubMed ID: 19421229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.
    Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; Ludwig H; Chen W; Cavo M; Harousseau JL; Lentzsch S; Hillengass J; Palumbo A; Orfao A; Rajkumar SV; Miguel JS; Avet-Loiseau H
    Lancet Oncol; 2016 Aug; 17(8):e328-e346. PubMed ID: 27511158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and opportunities of novel imaging techniques in monoclonal plasma cell disorders: imaging "early myeloma".
    Hillengass J; Landgren O
    Leuk Lymphoma; 2013 Jul; 54(7):1355-63. PubMed ID: 23289361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
    Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
    Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multiple Myeloma - Current Status in Diagnostic Testing and Therapy].
    Kehrer M; Koob S; Strauss A; Wirtz DC; Schmolders J
    Z Orthop Unfall; 2017 Oct; 155(5):575-586. PubMed ID: 28806822
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for acquisition, interpretation and reporting of whole body low dose CT in patients with multiple myeloma and other plasma cell disorders: a report of the IMWG Bone Working Group.
    Moulopoulos LA; Koutoulidis V; Hillengass J; Zamagni E; Aquerreta JD; Roche CL; Lentzsch S; Moreau P; Cavo M; Miguel JS; Dimopoulos MA; Rajkumar SV; Durie BGM; Terpos E; Delorme S
    Blood Cancer J; 2018 Oct; 8(10):95. PubMed ID: 30287814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Critical Role of Imaging in the Management of Multiple Myeloma.
    Raza S; Leng S; Lentzsch S
    Curr Hematol Malig Rep; 2017 Jun; 12(3):168-175. PubMed ID: 28317080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Modern imaging techniques in patients with multiple myeloma].
    Bannas P; Kröger N; Adam G; Derlin T
    Rofo; 2013 Jan; 185(1):26-33. PubMed ID: 23196838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma and macroglobulinemia: what are the criteria for diagnosis?
    Stone MJ
    Clin Lymphoma; 2002 Jun; 3(1):23-5. PubMed ID: 12141951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.